Skip to main content
NCBI home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1976 May;52(4):453–465.

The Concept of Autoimmune Liver Disease*

Ian R Mackay
PMCID: PMC1807167  PMID: 19312943

Full text

PDF
453

Images in this article

458Fig. 1b
on p.458
459Fig. 1c
on p.459

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Denman A. M., Barnes R. D. Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet. 1971 Jul 17;2(7716):135–140. doi: 10.1016/s0140-6736(71)92306-3. [DOI] [PubMed] [Google Scholar]
  2. Benacerraf B., McDevitt H. O. Histocompatibility-linked immune response genes. Science. 1972 Jan 21;175(4019):273–279. doi: 10.1126/science.175.4019.273. [DOI] [PubMed] [Google Scholar]
  3. Blumberg B. S., Gerstley B. J., Hungerford D. A., London W. T., Sutnick A. I. A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med. 1967 May;66(5):924–931. doi: 10.7326/0003-4819-66-5-924. [DOI] [PubMed] [Google Scholar]
  4. COWLING D. C., MACKAY I. R., TAFT L. I. Lupoid hepatitis. Lancet. 1956 Dec 29;271(6957):1323–1326. doi: 10.1016/s0140-6736(56)91483-0. [DOI] [PubMed] [Google Scholar]
  5. Doniach D., Roitt I. M., Taylor K. B. Autoimmunity in pernicious anemia and thyroiditis: a family study. Ann N Y Acad Sci. 1965 Jun 30;124(2):605–625. doi: 10.1111/j.1749-6632.1965.tb18990.x. [DOI] [PubMed] [Google Scholar]
  6. Freudenberg J., Erdmann K., Meyer zum Büschenfelde, Förster E., Berger J. HL-A bei Lebereerkrankungen. Klin Wochenschr. 1973 Nov;21(1):1075–1076. doi: 10.1007/BF01468323. [DOI] [PubMed] [Google Scholar]
  7. GAJDUSEK D. C. An autoimmune reaction against human tissue antigens in certain acute and chronic diseases. I. Serological investigations. AMA Arch Intern Med. 1958 Jan;101(1):9–29. doi: 10.1001/archinte.1958.00260130023003. [DOI] [PubMed] [Google Scholar]
  8. Galbraith R. M., Eddleston A. L., Smith M. G., Williams R., McSween R. N., Watkinson G., Dick H., Kennedy L. A., Batchelor J. R. Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis. Br Med J. 1974 Sep 7;3(5931):604–605. doi: 10.1136/bmj.3.5931.604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Galbraith R. M., Smith M., Mackenzie R. M., Tee D. E., Doniach D., Williams R. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N Engl J Med. 1974 Jan 10;290(2):63–69. doi: 10.1056/NEJM197401102900201. [DOI] [PubMed] [Google Scholar]
  10. Gershon R. K. T cell control of antibody production. Contemp Top Immunobiol. 1974;3:1–40. doi: 10.1007/978-1-4684-3045-5_1. [DOI] [PubMed] [Google Scholar]
  11. Golding P. L., Smith M., Williams R. Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis. Am J Med. 1973 Dec;55(6):772–782. doi: 10.1016/0002-9343(73)90258-1. [DOI] [PubMed] [Google Scholar]
  12. Henson J. B., Gorham J. R. Persistent viral infections, immunologically mediated glomerulonephritis and arteritis, dysgammopathies. Aleutian disease of mink. Am J Pathol. 1973 May;71(2):345–348. [PMC free article] [PubMed] [Google Scholar]
  13. Irvine W. J. Autoimmunity in endocrine disease. Proc R Soc Med. 1974 Jun;67(6 Pt 2):548–556. doi: 10.1177/00359157740676P207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. JOSKE R. A., KING W. E. The L.E.-cell phenomenon in active chronic viral hepatitis. Lancet. 1955 Sep 3;269(6888):477–480. doi: 10.1016/s0140-6736(55)93331-6. [DOI] [PubMed] [Google Scholar]
  15. LAWRENCE H. S. Homograft sensitivity. An expression of the immunologic origins and consequences of individuality. Physiol Rev. 1959 Oct;39:811–859. doi: 10.1152/physrev.1959.39.4.811. [DOI] [PubMed] [Google Scholar]
  16. MACKAY I. R., GAJDUSEK D. C. An autoimmune reaction against human tissue antigens in certain acute and chronic diseases. II. Clinical correlations. AMA Arch Intern Med. 1958 Jan;101(1):30–46. doi: 10.1001/archinte.1958.00260130044004. [DOI] [PubMed] [Google Scholar]
  17. MACKAY I. R. The problem of persisting destructive disease of the liver. Gastroenterology. 1961 May;40:617–626. [PubMed] [Google Scholar]
  18. MIESCHER P., FAUCONNET M. L'absorption du facteur L. E. par des noyaux cellulaires isolés. Experientia. 1954 Jun 15;10(6):252–253. doi: 10.1007/BF02157392. [DOI] [PubMed] [Google Scholar]
  19. Mackay I. R. Autoimmune disease. Med J Aust. 1969 Mar 29;1(13):696–699. doi: 10.5694/j.1326-5377.1969.tb105459.x. [DOI] [PubMed] [Google Scholar]
  20. Mackay I. R. Immunosuppressive drugs and chronic hepatitis. Med J Aust. 1972 Jun 3;1(23):1207–1210. doi: 10.5694/j.1326-5377.1972.tb116572.x. [DOI] [PubMed] [Google Scholar]
  21. Mackay I. R., Morris P. J. Association of autoimmune active chronic hepatitis with HL-A1,8. Lancet. 1972 Oct 14;2(7781):793–795. doi: 10.1016/s0140-6736(72)92149-6. [DOI] [PubMed] [Google Scholar]
  22. Miller J., Smith M. G., Mitchell C. G., Reed W. D., Eddleston A. L., Williams R. Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet. 1972 Aug 12;2(7772):296–297. doi: 10.1016/s0140-6736(72)92904-2. [DOI] [PubMed] [Google Scholar]
  23. Prince A. M. An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A. 1968 Jul;60(3):814–821. doi: 10.1073/pnas.60.3.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. ROITT I. M., DONIACH D., CAMPBELL P. N., HUDSON R. V. Auto-antibodies in Hashimoto's disease (lymphadenoid goitre). Lancet. 1956 Oct 20;271(6947):820–821. doi: 10.1016/s0140-6736(56)92249-8. [DOI] [PubMed] [Google Scholar]
  25. Reynolds T. B., Peters R. L., Yamada S. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med. 1971 Oct 7;285(15):813–820. doi: 10.1056/NEJM197110072851501. [DOI] [PubMed] [Google Scholar]
  26. Summerskill W. H. Chronic active liver disease reexamined: prognosis hopeful. Gastroenterology. 1974 Mar;66(3):450–464. [PubMed] [Google Scholar]
  27. Toh B. H., Roberts-Thomson I. C., Mathews J. D., Whittingham S., Mackay I. R. Depression of cell-mediated immunity in old age and the immunopathic diseases, lupus erythematosus, chronic hepatitis and rheumatoid arthritis. Clin Exp Immunol. 1973 Jun;14(2):193–202. [PMC free article] [PubMed] [Google Scholar]
  28. WITEBSKY E., ROSE N. R., TERPLAN K., PAINE J. R., EGAN R. W. Chronic thyroiditis and autoimmunization. J Am Med Assoc. 1957 Jul 27;164(13):1439–1447. doi: 10.1001/jama.1957.02980130015004. [DOI] [PubMed] [Google Scholar]
  29. Whittingham S., Mackay I. R., Whitworth J. A., Sloman G. Antinuclear antibody response to procainamide in man and laboratory animals. Am Heart J. 1972 Aug;84(2):228–234. doi: 10.1016/0002-8703(72)90337-7. [DOI] [PubMed] [Google Scholar]
  30. Whittingham S., Youngchaiyud U., Mackay I. R., Buckley J. D., Morris P. J. Thyrogastric autoimmune disease. Studies on the cell-mediated immune system and histocompatibility antigens. Clin Exp Immunol. 1975 Feb;19(2):289–299. [PMC free article] [PubMed] [Google Scholar]
  31. YOUNG L. E., MILLER G., CHRISTIAN R. M. Clinical and laboratory observations on autoimmune hemolytic disease. Ann Intern Med. 1951 Sep;35(3):507–517. doi: 10.7326/0003-4819-35-3-507. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES